abstract |
The present invention is related to a pharmaceutical composition comprising a poloxamer-based micellar system, 15-deoxy-Δ-12,14-prostaglandin J2 as the active ingredient and an aqueous carrier, with prolonged residence time at the site of injection, inducing potent and sustained analgesic and anti-inflammatory effect, being particularly useful for treatment of inflammatory conditions of joints and arthritis. |